7-10982925-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001007157.2(PHF14):āc.666A>Cā(p.Lys222Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,611,034 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001007157.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHF14 | NM_001007157.2 | c.666A>C | p.Lys222Asn | missense_variant | 3/18 | ENST00000634607.2 | NP_001007158.1 | |
PHF14 | NM_014660.4 | c.666A>C | p.Lys222Asn | missense_variant | 3/17 | NP_055475.2 | ||
PHF14 | NR_033435.2 | n.565-7778A>C | intron_variant | |||||
PHF14 | NR_033436.2 | n.565-7778A>C | intron_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152182Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000375 AC: 9AN: 240242Hom.: 0 AF XY: 0.0000537 AC XY: 7AN XY: 130334
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1458734Hom.: 1 Cov.: 35 AF XY: 0.0000317 AC XY: 23AN XY: 725298
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152300Hom.: 0 Cov.: 31 AF XY: 0.0000268 AC XY: 2AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2022 | The c.666A>C (p.K222N) alteration is located in exon 3 (coding exon 3) of the PHF14 gene. This alteration results from a A to C substitution at nucleotide position 666, causing the lysine (K) at amino acid position 222 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at